期刊文献+

PAK4促进人乳腺肿瘤细胞G1/S期转化机制探讨 被引量:7

Mechanism research of PAK4 promotes breast cancer cells in G_1/S phase transition
原文传递
导出
摘要 目的研究p21蛋白激活激酶4(p21protein activated kinase 4,PAK4)对人乳腺肿瘤细胞生长的影响。方法人乳腺肿瘤细胞MCF-7转染不同剂量PAK4真核表达载体或慢病毒敲除PAK4表达,收集细胞提取蛋白进行蛋白质印迹法检测PAK4和Cyclin D1表达。流式细胞仪检测PAK4过表达和敲除后对细胞生长周期影响。结果过表达PAK4明显上调人乳腺肿瘤细胞MCF-7中的Cyclin D1蛋白表达,引起G1期细胞减少(从80%下降到55%),导致G1/S期转化细胞增多。慢病毒敲除人乳腺肿瘤细胞MCF-7中的PAK4表达降低了的Cyclin D1蛋白表达,使G1期的细胞增加12%,而S期的细胞下调7%。结论 PAK4调节Cyclin D1表达,促进人乳腺肿瘤细胞MCF-7G1/S期转化,揭示PAK4可能是重要的人乳腺肿瘤治疗靶点。 OBJECIIVE To examine the influence of p21-activated kinases(PAK4) on the proliferation of human breast cancer cells MCF-7.METHODS Human breast cancer cells MCF-7 were treated with increasing concentrations of PAK4 constructs,and whole-cell lysates were extracted.Lysates containing equal amounts of protein were immunoblotted with PAK4 and Cyclin D1 antibody.Cell cycle was analyzed by flow cytometry assay.Inhibiting PAK4,by PAK4-RNAi-lentivirus,cell cycle was analyzed by flow cytometry assay.RESULTS The increased expression of PAK4 obviously upregulated the levels of Cyclin D1 protein and shortened G1 (down from 80 % to 55 %) and accelerated the G1/S-phase transition.When human breast cancer cells MCF-7 were transfected with a shRNA-lentivirus against PAK4,the levels of Cyclin D1 protein were decreased and there was 12% increase in G1 phase and 7% reduction in S phase.CONCLUSIONS We showed a novel mechanism of modulation of cell proliferation by PAK4 through up-regulation of Cyclin D1 in human breast cancer cells MCF-7.PAK4 promotes G1/S transition in human breast cancer cells MCF-7,which is critical for the design of targeted therapies against human breast cancer.
出处 《中华肿瘤防治杂志》 CAS 北大核心 2015年第3期165-168,共4页 Chinese Journal of Cancer Prevention and Treatment
基金 国家自然科学基金(31171360)
关键词 乳腺肿瘤 p21蛋白激活激酶4 CYCLIN D1 细胞周期 慢病毒 breast neoplasms p21 protein activated kinase 4(PAK4) Cyclin D1 cell cycle lentivirus
  • 相关文献

参考文献18

  • 1Minden A. The pak4 protein kinase in breast cancer [J]. ISRNOncol,2012,2012:694201. 被引量:1
  • 2Wang C,Li Y,Zhang H,et al. Oncogenic PAK4 regulates Smad2/3axis involving gastric tumorigenesis [J]. Oncogene, 2014, 33 (26):3473-3484. 被引量:1
  • 3Li Y, Shao Y, Tong Y, et al. Nucleo-cytoplasmic shuttling ofPAK4 modulates beta-catenin intracellular translocation and sig-naling [j]. Biochim Biophys Acta,2012,1823(2) :465-475. 被引量:1
  • 4Li Q,Ding C,Chen C,et al. miR-224 promotes cell migration andinvasion by modulating p-PAK4 and MMP-9 via targetingHOXD10 in human hepatocellular carcinoma [J]. J Gastroen-terol Hepatol.2014,29(4) :835-842. 被引量:1
  • 5Begum A* Imoto I, Kozaki K, et al. Identification of PAK4 as aputative target gene for amplification within 19ql3. 12-ql3. 2 inoral squamous-cell carcinoma [J]. Cancer Sci, 2009 , 100(10):1908-1916. 被引量:1
  • 6Siu MK,Chan HY,Kong DS,et al. p21-activated kinase 4 regu-lates ovarian cancer cell proliferation.migration, and invasion andcontributes to poor prognosis in patients [J]. Proc Natl Acad SciU S A,2010,107(43):18622-18627. 被引量:1
  • 7Park MH. Lee HS,Lee CS, et al. p21-Activated kinase 4 pro-motes prostate cancer progression through CREB [J]. Onco-gene,2013^32(19):2475-2482. 被引量:1
  • 8吴春丽,蔡峰,孙成英.AICAR对三阴性乳腺癌体外抑制作用及其机制的探讨[J].中华肿瘤防治杂志,2013,20(17):1310-1314. 被引量:5
  • 9Guo Q,Su N,Zhang J,et al. PAK4 kinase-mediated SCG10 phospho-rylation involved in gastric cancer metastasis [J]. Oncogene,2014,33(25):3277-3287. 被引量:1
  • 10Li RJ,Wang J,Xu Z,et al. Computational insight into p21-acti-vated kinase 4 inhibition:a combined ligand- and structure-baseda卯roach [J]. Chem Med Chem,2014,9(5) :1012-1022. 被引量:1

二级参考文献24

  • 1王晓艳,沈守荣,刘芬,李晓玲,范松青.NGX6基因对人结肠癌细胞HT-29细胞周期的影响[J].生物化学与生物物理进展,2006,33(1):45-50. 被引量:14
  • 2陈小贺,孟文格,孟繁杰,李保东,薛平,蔡建辉.大肠癌组织中CyclinD1和p16及Rb的表达及其临床意义[J].中华肿瘤防治杂志,2006,13(1):38-41. 被引量:9
  • 3SJ Moghaddam,EN Haghighi,S Samiee,N Shahid,AR Keramati,S Dadgar,MR Zali.Immunohistochemical analysis of p53,cyclinD1,RB1,c-fos and N-ras gene expression in hepatocellular carcinoma in Iran[J].World Journal of Gastroenterology,2007,13(4):588-593. 被引量:73
  • 4Rastelli F, Biancanelli S, Falzetta A, et al. Triple-negative breast- cancer:Current state of the art[J]. Tumori,2010,96(6): 875- 888. 被引量:1
  • 5De Ruijter TC, Veeck J ,de Hoon JP, et al. Characteristics of tri- ple-negative breast cancer [J]. J Cancer Res Clin Oncol,2011, 137(2) : 183-192. 被引量:1
  • 6Mihaylova MM, Shaw RJ. The AMPK signalling pathway coordi- nates cell growth,autophagy and metabolism[J]. Nat Cell Biol, 2011,13(9) : 1016-1023. 被引量:1
  • 7Lee CW,Wong LL,Tse EY,et al. AMPK promotes p53 acetyla- tion Via phosphorylation and inactivation of SIRT1 in liver cancer cells[J]. Cancer Res,2012,72(17) :4394-4404. 被引量:1
  • 8Liu J, Liu W, Ying H, et al, Analysis of microRNA expression profile induced by AICAR in mouse hepatocytes[J]. Gene, 2013, 10(2) : 364-372. 被引量:1
  • 9Theodoropoulou S, Brodowska K,Kayama M, et al, Aminoimidazole carboxamide ribonucleotide (AICAR) inhibits the growth of retino- blastoma in vivo by decreasing angiogenesis and inducing apoptosis[J]. PLoS One,2013,8(1) ,e52852. 被引量:1
  • 10Sauer H, Engel S, Milosevic N, et al, Activation of AMP-kinase by AICAR induces apoptosis of DU-145 prostate cancer cells through generation of reactive oxygen species and activation of c- Jun N-terminal kinase[J]. Int J Oncol, 2012,40(2) : 501-508. 被引量:1

共引文献6

同被引文献34

引证文献7

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部